Edgewise Therapeutics, Inc.

This early-stage study is testing a new oral drug called EDG-15400 in 108 healthy adults aged 18 to 59. The main goal is to check if the drug is safe and how well it is tolerated, both after a single dose and after multiple doses. Researchers will also measure how much of the dru…

This early-stage study tests the safety of a new drug called EDG-7500 in 24 healthy adults, both Japanese and Caucasian. Participants receive single or multiple doses, and researchers measure how the drug moves through the body. No treatment benefit is expected; the goal is to ga…

This early-stage study is testing a single dose of an experimental drug called EDG-7500 in 32 adults. Some have mild or moderate liver problems, while others have normal liver function. Researchers want to see how the drug moves through the body and if it is safe in people with d…

This study looked at how a single dose of the drug EDG-7500 stays in the blood of people with various levels of kidney function, from normal to severely impaired. It involved 37 adults aged 18-75. The goal was to understand if kidney problems change drug levels, which helps docto…